News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nuventra Pharma Sciences Appoints Mark A. Bush, Ph.D. As Chief Scientific Officer


2/27/2014 7:02:41 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Nuventra Pharma Sciences, a specialty pharmaceutical consulting firm with global reach, today announced that Mark A. Bush, Ph.D. has been appointed to the role of Chief Scientific Officer (CSO). Dr. Bush had served as the Senior Director, Clinical Pharmacokinetics (PK) at Nuventra prior to assuming duties as CSO. Dr. Bill Wargin, who had been CSO since the company’s inception, remains with the company in an emeritus position as Executive Vice President of Pharmacokinetics.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES